Skip to main content
News

May’s visit yields US$1.3b in Chinese funds for British biotech and life sciences companies | South China Morning Post

By February 5, 2018No Comments
china-flag-2-pixa

china-flag-2-pixa

China’s increasing zeal for improving biotechnology and medical services is music to the ears of the British government after two venture capital firms received 8 billion yuan (US$1.3 billion) in funding commitments from mainland investors during Prime Minister Theresa May’s three-day visit last week.

{iframe}http://www.scmp.com/business/global-economy/article/2131943/mays-visit-yields-us13b-chinese-funds-british-biotech-and{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.